Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Marjory Maclennan"'
Autor:
Marjory MacLennan, Karin Purshouse, Sally Clive, Mark Stares, C. Barrie, Rachel Haigh, Rebekah Patton, Aoife Gatenby, Jo McGinty, Jenny Irvine, Alan Christie, Gillian Knowles
Publikováno v:
British Journal of Cancer
Stares, M, Purshouse, K, Knowles, G, Haigh, R, Irvine, J, Gatenby, A, Patton, R, Mcginty, J, Christie, A, Maclennan, M, Barrie, C & Clive, S 2021, ' Characterisation and outcomes of patients referred to a regional cancer of unknown primary team: a 10-year analysis ', British Journal of Cancer . https://doi.org/10.1038/s41416-021-01544-1
Stares, M, Purshouse, K, Knowles, G, Haigh, R, Irvine, J, Gatenby, A, Patton, R, Mcginty, J, Christie, A, Maclennan, M, Barrie, C & Clive, S 2021, ' Characterisation and outcomes of patients referred to a regional cancer of unknown primary team: a 10-year analysis ', British Journal of Cancer . https://doi.org/10.1038/s41416-021-01544-1
Background In the United Kingdom, national guidance published in 2010 recommended the establishment of specialist teams to improve clinical pathways for patients presenting with malignancies of undefined primary origin (MUO) and cancer of unknown pri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::777959296c52003605364f57ec5c03bc
http://europepmc.org/articles/PMC8608886
http://europepmc.org/articles/PMC8608886
Autor:
Adrian Murray Brunt, Joanne S Haviland, Duncan A Wheatley, Mark A Sydenham, Abdulla Alhasso, David J Bloomfield, Charlie Chan, Mark Churn, Susan Cleator, Charlotte E Coles, Andrew Goodman, Adrian Harnett, Penelope Hopwood, Anna M Kirby, Cliona C Kirwan, Carolyn Morris, Zohal Nabi, Elinor Sawyer, Navita Somaiah, Liba Stones, Isabel Syndikus, Judith M Bliss, John R Yarnold, Anne Armstrong, Judith Bliss, David Bloomfield, Jo Bowen, Murray Brunt, Hannah Chantler, Charlotte Coles, Ellen Donovan, Andy Goodman, Susan Griffin, Jo Haviland, Penny Hopwood, Anna Kirby, Julie Kirk, Cliona Kirwan, Marjory MacLennan, Mark Sculphur, Judith Sinclair, Mark Sydenham, Jean Tremlett, Karen Venables, Duncan Wheatley, John Yarnold
Publikováno v:
Lancet (London, England)
FAST-Forward Trial Management Group 2020, ' Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward) : 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial ', Lancet (London, England), vol. 395, no. 10237, pp. 1613-1626 . https://doi.org/10.1016/S0140-6736(20)30932-6
FAST-Forward Trial Management Group 2020, ' Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward) : 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial ', Lancet (London, England), vol. 395, no. 10237, pp. 1613-1626 . https://doi.org/10.1016/S0140-6736(20)30932-6
BACKGROUND: We aimed to identify a five-fraction schedule of adjuvant radiotherapy (radiation therapy) delivered in 1 week that is non-inferior in terms of local cancer control and is as safe as an international standard 15-fraction regimen after pri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53e395035946033bfb3c8db03e2d044a
Autor:
David Cameron, Sarah H. Wild, Maighread Simpson, Marjory Maclennan, Peter Hall, Christina Lilley, Peter Henriksen, Kelly Rust, Richard Stoker, Jeremy Walker
Publikováno v:
Journal of Clinical Oncology. 35:553-553
553 Background: Anthracycline chemotherapy is used frequently in adjuvant breast cancer treatment but there is clinical trial evidence of cardiac toxicity. Attempts to quantify this risk in routine care have been limited by follow up time & confoundi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fd7b942a8f1211e3fbdd4c99905b7fff
https://doi.org/10.1200/jco.2017.35.15_suppl.553
https://doi.org/10.1200/jco.2017.35.15_suppl.553